Pneumonitis in the combination therapy of immune checkpoint inhibitors and chemotherapy: a meta-analysis of phase 3 randomized clinical trials
Not Applicable
- Conditions
- Solid tumors
- Registration Number
- JPRN-UMIN000041916
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel Department of Medicine
- Brief Summary
Please see: Eur J Cancer. 2021 Jun;150:168-178. doi: 10.1016/j.ejca.2021.03.012.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15006
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Systematic review or meta-analysis articles. (2) Retrospective analysis. (3) Single prospective cohort study without a control group. (4) Non-RCT. (5) The republished research literature is excluded unless the research includes new findings related to adverse events listed in inclusion criteria. (6) Studies with no or insufficient safety results at the time of the literature search. (7) Studies published in languages other than English.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method